Aggravation of epilepsy by anti-epileptic drugs
Open accessAbstract
The possibility that so‐called anti‐epileptic drugs (AEDs) may aggravate epilepsy must always be borne in mind by the clinician. Many reports of such aggravation of seizures have been published. Most such reports are anecdotal and speculative, and suggest that many such reactions are idiosyncratic. However, for some there is a sufficient body of evidence to suggest that some AEDs used in certain epilepsies may consistently cause worsening of seizures. Seizure aggravation may include increase in the frequency or severity of existing seizures, emergence of new types of seizure, or the occurrence of status epilepticus. The pathophysiology of seizure aggravation is poorly understood including nonspecific effects such as those associated with sedation, druginduced encephalopathy, and paradoxical or inverse pharmacodynamic effects. For some epilepsies the choice of AEDs may be inappropriate, and although the mechanism of seizure aggravation is not clear, its occurrence may be fairly predictable. This is best documented for the use of carbamazepine in idiopathic generalized and myoclonic epilepsies. Most other AEDs have been reported occasionally to cause seizure aggravation. The lowest risk of seizure aggravation appears to be with valproate. Risk factors for worsening of seizures are epileptic encephalopathy, polytherapy, high frequency of seizures, and cognitive impairment. Advances in pharmacogenomics may in the future enable such adverse effects to be predicted for individual patients. Meanwhile, a systematic approach to reporting AED‐induced seizure aggravation should be developed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Paradoxical excitement is sometimes associated with benzodiazepine use and may include exacerbation of seizures in patients with epilepsy.
“Paradoxical excitement is sometimes associated with BZD use and may include exacerbation of seizures in patients with epilepsy (171).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [171]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy
Guerrini, R., Dravet, C., Genton, P., Belmonte, A., Kaminska, A., & Dulac†, O. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01413.x · Cited by 467 · see citing works
Genetic susceptibility to adverse drug reactions
Pirmohamed, M., & Park, B. K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01717-x · Cited by 328 · see citing works
Suzdak, P. D., & Jansen, J. A. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb02576.x · Cited by 278 · see citing works
Atypical Benign Partial Epilepsy of Childhood
Aicardi, J. F., & Chevrie, J. J. (1982) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1982.tb13620.x · Cited by 251 · see citing works
Exacerbation of Seizures in Children by Carbamazepine
Snead, O. C., & Hosey, L. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510103131503 · Cited by 237 · see citing works
Landau‐Kleffner Syndrome: A Pharmacologic Study of Five Cases
Marescaux, C., Hirsch, É., Finck, S., Maquet, P., Schlumberger, É., Sellal, F., Metz‐Lutz, M., Alembik, Y., Salmon, É., Franck, G., et al. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05518.x · Cited by 211 · see citing works
"BALTIC" MYOCLONUS EPILEPSY: HEREDITARY DISORDER OF CHILDHOOD MADE WORSE BY PHENYTOIN
Eldridge, R. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90749-3 · Cited by 180 · see citing works
Status Epilepticus: Mechanisms of Brain Damage and Treatment
Levy, R. H. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050150030010 · Cited by 160 · see citing works
Tassinari, C. A., Dravet, C., Roger, J., Cano, J. P., & Gastaut, H. (1972) · Epilepsia · doi:10.1111/j.1528-1157.1972.tb04582.x · Cited by 144 · see citing works
Aicardi's Epilepsy in Children
Jellinger, K. A. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00881.x · Cited by 136 · see citing works
Seizure and EEG Patterns in Angelman's Syndrome
Viani, F., Romeo, A., Viri, M., Mastrangelo, M., Lalatta, F., Selicorni, A., Gobbi, G., Lanzi, G., Bettio, D., Briscioli, V., et al. (1995) · Journal of Child Neurology · doi:10.1177/088307389501000609 · Cited by 113 · see citing works
Seizure-inducing effects of antiepileptic drugs: a review
Bauer, J. M. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00047.x · Cited by 112 · see citing works
Myoclonus Associated with the Use of Gabapentin
Asconapé, J. J., Diedrich, A., & DellaBadia, J. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00192.x · Cited by 108 · see citing works
Tiagabine-induced absence status in idiopathic generalized epilepsy
Knake, S., Hamer, H. M., Schomburg, U., Oertel, W. H., & Rosenow, F. (1999) · Seizure · doi:10.1053/seiz.1999.0303 · Cited by 101 · see citing works
Carbamazepine-exacerbated epilepsy in children and adolescents
Horn, C. S., Ater, S. B., & Hurst, D. L. (1986) · Pediatric Neurology · doi:10.1016/0887-8994(86)90074-3 · Cited by 97 · see citing works
Aronson, J. K. (2003) · BMJ · doi:10.1136/bmj.326.7403.1346 · Cited by 95 · see citing works
Nakken, K. O., Eriksson, A.-S., Lossius, R., & Johannessen, S. I. (2002) · Seizure · doi:10.1016/s1059131102001723 · Cited by 89 · see citing works
Lortie, A., Chiron, C., Mumford, J. P., & Dulac, O. (1993) · PubMed · Cited by 83 · see citing works
Myoclonic status epilepticus following high-dosage lamotrigine therapy
Guerrini, R., Belmonte, A., Parmeggiani, L., & Perucca, E. (1999) · Brain and Development · doi:10.1016/s0387-7604(99)00048-0 · Cited by 82 · see citing works
Seizure exacerbation and status epileptics related to carbamazepine‐10,11‐epoxide
So, E. L., Ruggles, K. H., Cascino, G. D., Ahmann, P. A., & Weatherford, K. W. (1994) · Annals of Neurology · doi:10.1002/ana.410350616 · Cited by 69 · see citing works
Phenytoin‐Induced Seizures: A Paradoxical Effect at Toxic Concentrations in Epileptic Patients
Osorio, I., Burastine, T. H., Render, B., Manon‐Espaillat, R., & Reed, R. C. (1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05459.x · Cited by 64 · see citing works
Progressive Encephalopathy Due to Chronic Hydantoin Intoxication
Vallarta, J. M. (1974) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1974.02110260029006 · Cited by 58 · see citing works
Prior, P. F., MACLAINE, G. N., Scott, D. F., & Laurance, B. M. (1972) · Epilepsia · doi:10.1111/j.1528-1157.1972.tb04586.x · Cited by 50 · see citing works
Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience
Mohamed, K., Appleton, R. E., & Rosenbloom, L. (2000) · Seizure · doi:10.1053/seiz.2000.0387 · Cited by 50 · see citing works
Non convulsive status epilepticus after replacement of valproate with lamotrigine
Trinka, E., Dilitz, E., Unterberger, I., Luef, G. J., Deisenhammer, F., Niedermüller, U., Thaler, C., & Bauer, G. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0857-3 · Cited by 47 · see citing works
Catania, S., Cross, J. H., de Sousa, C., & Boyd, S. G. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02053.x · Cited by 44 · see citing works
Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin.
Vossler, D. G. (1996) · PubMed · Cited by 44 · see citing works
Exacerbation of Partial Seizures and Onset of Nonepileptic Myoclonus with Carbamazepine
Dhuna, A. K., Pascual‐Leone, Á., & Talwar, D. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb05255.x · Cited by 42 · see citing works
Epileptic negative myoclonus induced by carbamazepine in a child with BECTS
Nanba, Y., & Maegaki, Y. (1999) · Pediatric Neurology · doi:10.1016/s0887-8994(99)00054-5 · Cited by 42 · see citing works
Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures
DiMario, F. J., & Clancy, R. R. (1988) · Pediatric Neurology · doi:10.1016/0887-8994(88)90040-9 · Cited by 39 · see citing works
Benzodiazepines: efficacy in status epilepticus.
Tassinari, C. A., Daniele, O., Michelucci, R., Bureau, M., Dravet, C., & Roger, J. (1983) · PubMed · Cited by 39 · see citing works
Clinical and EEG findings in complex partial status epilepticus with tiagabine
Trinka, E., Moroder, T., Nagler, M., Staffen, W., ̈scher, W. L., & Ladurner, G. (1999) · Seizure · doi:10.1053/seiz.1998.0223 · Cited by 36 · see citing works
Topiramate in Intractable Childhood Onset Epilepsy - A Cautionary Note
Dooley, J. M., Camfield, P. R., Smith, E. I., Langevin, P., & Ronen, G. M. (1999) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000366 · Cited by 33 · see citing works
Alertness and Incidence of Seizures in Patients with Lennox‐Gastaut Syndrome
Papini, M., Pasquinelli, A., Armellini, M., & Orlandi, D. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb04172.x · Cited by 33 · see citing works
Marciani, M. G., Maschio, M. C. E., Spanedda, F., Iani, C., Gigli, G. L., & Bernardi, G. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb05834.x · Cited by 33 · see citing works
Topiramate for drug-resistant epilepsies
Yeung, S., Ferrie, C. D., Murdoch‐Eaton, D. G., & Livingston, J. H. (2000) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.1999.0257 · Cited by 25 · see citing works
Self-citationAcute encephalopathy with vigabatrin
Sälke-Kellermann, A., Baier, H., Rambeck, B., Boenigk, H. E., & Wolf, P. (1993) · The Lancet · doi:10.1016/0140-6736(93)91397-5 · Cited by 25 · see citing works
Non-convulsive status epilepticus resistant to benzodiazepines.
Livingston, J. H., & Brown, J. Κ. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.1.41 · Cited by 22 · see citing works
Self-citationValproate-associated encephalopathy
Pakalnis, A., Drake, M. E., & Denio, L. S. (1989) · Journal of Epilepsy · doi:10.1016/0896-6974(89)90057-1 · Cited by 18 · see citing works
Epileptic Seizures Induced by Clonazepam
Álvarez, N., Hartford, E., & Doubt, C. (1981) · Clinical Electroencephalography · doi:10.1177/155005948101200203 · Cited by 18 · see citing works
Rangel, R. J., Warner, J. J., & Wilder, B. J. (1988) · Journal of Epilepsy · doi:10.1016/s0896-6974(88)80014-8 · Cited by 11 · see citing works
Seizure disorders. A pharmacological approach to treatment
Hughes, J. R. (1982) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(82)90169-9 · Cited by 5 · see citing works
Barbiturates: phenobarbital, mephobarbital and metharbital
Wilder, B. (1981) · Medical Entomology and Zoology · Cited by 5 · see citing works
Die Carbamazepin-Enzephalopathie - eine seltene Nebenwirkung
Neumann, B., & Steinhoff, B. J. (1994) · Aktuelle Neurologie · doi:10.1055/s-2007-1017981 · Cited by 4 · see citing works
Encephalomyelopathy as an idiosyncratic reaction to carbamazepine: A case report
Smith, C. R. (1991) · Neurology · doi:10.1212/wnl.41.5.760-a · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511 · see citing works
Löscher, W., & Klein, P. (2021) · CNS Drugs · doi:10.1007/s40263-021-00827-8 · Cited by 381 · see citing works
Computer modelling of epilepsy
Lytton, W. W. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2416 · Cited by 286 · see citing works
Current understanding of the mechanism of action of the antiepileptic drug lacosamide
Rogawski, M. A., Tofighy, A., White, H. S., Matagne, A., & Wolff, C. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.11.021 · Cited by 208 · see citing works
Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development
Wahab, A. (2010) · Pharmaceuticals · doi:10.3390/ph3072090 · Cited by 160 · see citing works
Reflex seizures, traits, and epilepsies: from physiology to pathology
Koepp, M. J., Caciagli, L., Pressler, R., Lehnertz, K., & Beniczky, S. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00219-7 · Cited by 113 · see citing works
Epilepsy in Rett syndrome—The experience of a National Rett Center
Nissenkorn, A., Gak, E., Vecsler, M., Reznik, H., Menascu, S., & Zeev, B. B. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02597.x · Cited by 99 · see citing works
The challenges of treating epilepsy with 25 antiepileptic drugs
Santulli, L., Coppola, A., Balestrini, S., & Striano, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.016 · Cited by 97 · see citing works
Treatment of Lennox-Gastaut syndrome: overview and recent findings
van Rijckevorsel, K. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1668 · Cited by 97 · see citing works
Perampanel: Does it have broad‐spectrum potential?
Potschka, H., & Trinka, E. (2018) · Epilepsia · doi:10.1111/epi.14456 · Cited by 90 · see citing works
The medical management of the epilepsies in children: conceptual and practical considerations
Raspall‐Chaure, M., Neville, B. G. R., & Scott, R. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70324-1 · Cited by 73 · see citing works
Copmans, D., Orellana-Paucar, A. M., Steurs, G., Zhang, Y., Ny, A., Foubert, K., Exarchou, V., Siekierska, A., Kim, Y., Borggraeve, W. M. D., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.11.011 · Cited by 71 · see citing works
Paradoxical and Bidirectional Drug Effects
Smith, S. W., Hauben, M., & Aronson, J. K. (2012) · Drug Safety · doi:10.2165/11597710-000000000-00000 · Cited by 70 · see citing works
Kerr, M., Kluger, G. J., & Philip, S. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0409 · Cited by 70 · see citing works
Talwar, A., Estes, E., Aparasu, R., & Reddy, D. S. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114238 · Cited by 66 · see citing works
A Simple Quantitative Method for Analyzing Electrographic Status Epilepticus in Rats
Lehmkuhle, M. J., Thomson, K. E., Scheerlinck, P. H., Pouliot, W. A., Greger, B. E., & Dudek, F. E. (2009) · Journal of Neurophysiology · doi:10.1152/jn.91062.2008 · Cited by 64 · see citing works
Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy
Guerrini, R., Zaccara, G., la Marca, G., & Rosati, A. (2012) · Drug Safety · doi:10.2165/11630700-000000000-00000 · Cited by 56 · see citing works
Aggravation of Seizures and/or EEG Features in Children Treated with Oxcarbazepine Monotherapy
Vendrame, M., Khurana, D. S., Cruz, M., Melvin, J. J., Valencia, I., Legido, A., & Kothare, S. V. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01210.x · Cited by 53 · see citing works
Pharmacological Activity of Pyrazole Derivatives as an Anticonvulsant for Benefit against Epilepsy
Gao, M., Qu, K., Zhang, W., & Wang, X. (2021) · NeuroImmunoModulation · doi:10.1159/000513297 · Cited by 48 · see citing works
Maheshwari, A., Nahm, W. K., & Noebels, J. L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00156 · Cited by 45 · see citing works
Ohtsuka, Y., Yoshinaga, H., Shirasaka, Y., Takayama, R., Takano, H., & Iyoda, K. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.01.002 · Cited by 44 · see citing works
Early Diagnosis and Treatment of Lennox-Gastaut Syndrome
Resnick, T., & Sheth, R. D. (2017) · Journal of Child Neurology · doi:10.1177/0883073817714394 · Cited by 37 · see citing works
Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam
Rogawski, M. A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106506 · Cited by 34 · see citing works
Managing Severe Epilepsy Syndromes of Early Childhood
Wheless, J. W. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338153 · Cited by 33 · see citing works
Massot, A., Vivanco, R. A., Príncipe, A., Roquer, J., & Rocamora, R. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.02.002 · Cited by 31 · see citing works
Massot‐Tarrús, A., Vivanco‐Hidalgo, R. M., Príncipe, A., Roquer, J., & Rocamora, R. (2013) · Neurología · doi:10.1016/j.nrl.2013.02.013 · Cited by 30 · see citing works
Douglas, J. F., Sanders, K. B., Benneyworth, M. H., Smith, J. L., DeJean, V. M., McGrew, S. G., & Veenstra-VanderWeele, J. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1661-2 · Cited by 30 · see citing works
Drugs that lower the seizure threshold
Hitchings, A. W. (2016) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000016 · Cited by 29 · see citing works
Booker, S. A., Pires, N. M., Cobb, S., Soares-da-Silva, P., & Vida, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.019 · Cited by 28 · see citing works
Clozapine-induced myoclonus: a case report and review of the literature
Osborne, I. J., & McIvor, R. J. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612015 · Cited by 27 · see citing works
Mostacci, B., Ranzato, F., Giuliano, L., Neve, A. L., Aguglia, U., Bilo, L., Durante, V., Ermio, C., Monti, G., Zambrelli, E., et al. (2020) · Seizure · doi:10.1016/j.seizure.2020.12.005 · Cited by 27 · see citing works
Kundap, U. P., Choo, B. K. M., Kumari, Y., Ahemad, N., Othman, I., & Shaikh, M. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01249 · Cited by 25 · see citing works
The risk of paradoxical levetiracetam effect is increased in mentally retarded patients
Szűcs, A., Clemens, Z., Jakus, R., Rásonyi, G., Fabó, D., Holló, A., Barcs, G., Kelemen, A., & Janszky, J. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01585.x · Cited by 25 · see citing works
Saleem, T., Sheikh, N., Abbasi, M. H., Javed, I., & Khawar, M. B. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107476 · Cited by 23 · see citing works
Franco, V., Barbieri, M. A., Cutroneo, P. M., Arena, I. G., Cicala, G., Marchione, P., Spina, E., & Perucca, E. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107989 · Cited by 23 · see citing works
Computational approaches for innovative antiepileptic drug discovery
Talevi, A. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1216965 · Cited by 21 · see citing works
Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults
Stephen, L. J., & Brodie, M. J. (2020) · CNS Drugs · doi:10.1007/s40263-020-00698-5 · Cited by 20 · see citing works
Non-convulsive status epilepticus in adults - an overview
Rüegg, S. J. (2008) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2008.01928 · Cited by 19 · see citing works
Molecular Mechanisms of Valproic Acid Action on Signalling Systems and Brain Functions
Tursunov, A. N., Vasilyev, D. S., & Nalivaeva, N. N. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023050228 · Cited by 18 · see citing works
Thalidomide for treatment of refractory epilepsy
Palencia, G., Martínez-Juárez, I. E., Calderón, A., Artigas, C., & Sotelo, J. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.10.003 · Cited by 18 · see citing works
Melani, F., Rosati, E., Chiocchetti, B., & Muscas, G. C. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.01.018 · Cited by 16 · see citing works
Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?
Zaccara, G., Mula, M., Ferrò, B., Consoli, D., Elia, M., Giallonardo, A. T., Iudice, A., Neve, A. L., Meletti, S., Tinuper, P., et al. (2018) · Epilepsia · doi:10.1111/epi.14622 · Cited by 16 · see citing works
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population
D’Onofrio, G., Roberti, R., Riva, A., Russo, E., Verrotti, A., Striano, P., & Belcastro, V. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00344 · Cited by 14 · see citing works
X-Linked Epilepsies: A Narrative Review
Bernardo, P., Cuccurullo, C., Rubino, M., Vita, G. D., Terrone, G., Bilo, L., & Coppola, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074110 · Cited by 14 · see citing works
Bergin, P., Sadleir, L. G., Legros, B., Mogal, Z., Tripathi, M., Dang, N., Beretta, S., Zanchi, C., Burneo, J. G., Borkowski, T. M., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03636.x · Cited by 14 · see citing works
Generalized Myoclonus and Spasticity Induced by Lamotrigine Toxicity
Algahtani, H. A., Aldarmahi, A. A., Al-Rabia, M. W., Almalki, W. H., & Young, G. B. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000020 · Cited by 12 · see citing works
Activity Clamp Provides Insights into Paradoxical Effects of the Anti-Seizure Drug Carbamazepine
Morris, G., Leite, M., Kullmann, D. M., Pavlov, I., Schorge, S., & Lignani, G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3697-16.2017 · Cited by 11 · see citing works
Jin, K., Obara, T., Hirano, K., Hirai, D., Kiuchi, M., Tanaka, T. Q., & Nakasato, N. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108841 · Cited by 11 · see citing works
Veerapandiyan, A., Singh, P. K., & Mikati, M. A. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0491 · Cited by 11 · see citing works
Particularités de la prise en charge des enfants ayant une épilepsie
Auvin, S. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2010.12.006 · Cited by 11 · see citing works
Principles of Therapy in the Epilepsies
PANAYIOTOPOULOS, C. P. (2010) · Springer eBooks · doi:10.1007/978-0-85729-009-0 · Cited by 10 · see citing works
Higuchi, T., Fukuyama, T., Misawa, Y., Inaba, Y., Ichikawa, M., & Koike, K. (2011) · Epileptic Disorders · doi:10.1684/epd.2011.0423 · Cited by 10 · see citing works
Principles of therapy in the epilepsies
Panayiotopoulos, C. P. (2010) · Springer eBooks · doi:10.1007/978-1-84628-644-5_7 · Cited by 10 · see citing works
Childhood epilepsies: What should a pediatrician know?
Bashiri, F. A. (2017) · Neurosciences · doi:10.17712/nsj.2017.1.20160244 · Cited by 10 · see citing works
Wang, G., Chou, P., Hsueh, S. W., Yang, Y., & Kuo, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105188 · Cited by 9 · see citing works
Arzimanoglou, A. A., Kalilani, L., Anamoo, M. A., Cooney, M., Golembesky, A., Taeter, C., Bozorg, A. M., Tofighy, A., & Wheless, J. W. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.05.002 · Cited by 8 · see citing works
Pharmacotherapy of idiopathic generalized epilepsies
Curatolo, P., Moavero, R., Castro, A. L., & Cerminara, C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802618647 · Cited by 7 · see citing works
Principles and Current Issues of Antiepileptic Drug Therapy
Pisani, L. R., Belcastro, V., Oteri, G., & Pisani, F. (2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608057580113010008 · Cited by 6 · see citing works
Rana, Z. S., Pathania, C., Modgil, A., & Punnakkal, P. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.016 · Cited by 5 · see citing works
Laroche, M., Labetoulle, M., Jouanjus, É., Kröger, E., & Zongo, A. (2025) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70028 · Cited by 5 · see citing works
Aggravation of symptomatic occipital epilepsy of childhood by carbamazepine
Škrijelj, F., & Mulić, M. (2014) · Vojnosanitetski pregled · doi:10.2298/vsp1404404s · Cited by 5 · see citing works
Psychiatric illness and psychotropic medication use in epilepsy
Perr, J. V., & Ettinger, A. B. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977145.016 · Cited by 5 · see citing works
Paradoxical phenomena in epilepsy
Schachter, S. C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511978098.013 · Cited by 4 · see citing works
Politerapia racional en epilepsia. II. Aspectos clínicos y farmacológicos
Armijo, J. A., & Herranz, J. L. (2007) · Revista de Neurología · doi:10.33588/rn.4503.2007260 · Cited by 4 · see citing works
Seizures exacerbated by antiepileptic drugs in children
Ong, L. C. (2010) · Cited by 4 · see citing works
Suspected induction of epileptic negative myoclonus after lacosamide initiation
Yamamoto, N., Kuki, I., Inoue, T., Yamada, N., Okazaki, S., Shide‐Moriguchi, Y., & Yoshida, S. (2025) · Epilepsia · doi:10.1111/epi.18595 · Cited by 3 · see citing works
Adrenergic mechanisms of absence status epilepticus
Sitnikova, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1298310 · Cited by 3 · see citing works
Kreir, M., Putri, D., Tekle, F. B., Pibiri, F., d’Ydewalle, C. V. O., Ammel, K. V., Geys, H., Teisman, A. C. H., Gallacher, D. J., & Lu, H. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1308547 · Cited by 3 · see citing works
Seizure Aggravation—Evidence that Oxcarbazepine Requires Monitoring
Ben‐Menachem, E. (2008) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2008.00252.x · Cited by 3 · see citing works
Seizure aggravation caused by antiepileptic drugs in a patient with muscle–eye–brain disease
Belcastro, V., Galletti, F., Giuglietti, M., Messina, S., Elia, M., Prontera, P., & Calabresi, P. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.09.010 · Cited by 3 · see citing works
Encefalopatía reversible por ácido valproico en un adolescente con epilepsia generalizada idiopática
Raspall‐Chaure, M., Samper, E. L., Toledo, M., Salas‐Puig, J., Macaya, A., & Roig-Quilis, M. (2012) · Revista de Neurología · doi:10.33588/rn.5511.2012374 · Cited by 2 · see citing works
Seizures, medical child abuse, and the pediatric neurologist
Goulbourne, M., & Huber, C. M. (2024) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2024.101137 · Cited by 2 · see citing works
Medication-Induced Seizures and Status Epilepticus
Zutshi, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-31230-9_22 · Cited by 2 · see citing works
Carbamazepine-induced seizure in a nonepileptic child
Benny, R., Bolegave, V., Sadawarte, S., & Khatav, V. (2017) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_169_17 · Cited by 2 · see citing works
Pharmacovigilance of unlicensed cannabidiol in European countries
Calapai, F., Esposito, E., Ammendolia, I., Mannucci, C., Calapai, G., Currò, M., Cardia, L., & Chinou, İ. (2023) · Phytotherapy Research · doi:10.1002/ptr.8028 · Cited by 2 · see citing works
Molecular Mechanisms of Valproic Acid Action on Signalling Systems and Brain Functions
Tursunov, A. N., Vasilyev, D. S., & Nalivaeva, N. N. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923100126 · Cited by 2 · see citing works
Drug-Induced Seizures in Critically Ill Patients
Rhoney, D. H., & Varelas, P. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-532-3_13 · Cited by 2 · see citing works
Electroencephalogram in unilateral multilobar polymicrogyria with nonconvulsive status epilepticus
Martinović, Ž., & Jović, N. (2007) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2007.05.009 · Cited by 2 · see citing works
Мukhin, К. Y., & Пылаева, О. А. (2015) · Russian Journal of Child Neurology · doi:10.17650/2073-8803-2015-10-2-38-53 · Cited by 2 · see citing works
Objectifs et aspects pratiques des médicaments antiépileptiques
Auvin, S. (2015) · Soins Pédiatrie/Puériculture · doi:10.1016/j.spp.2015.01.003 · Cited by 1 · see citing works
Management of Idiopathic Generalized Epilepsies
Ferrie, C. D. (2010) · Springer eBooks · doi:10.1007/978-1-84882-128-6_156 · Cited by 1 · see citing works
Lacosamide Reduces Seizure Severity but Increases Seizure Frequency in PTZ-Kindled Rats
Gáll, Z., Koncz, S., Gáll, O., & Kolcsár, M. (2017) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2017-0037 · Cited by 1 · see citing works
Inducción de crisis de ausencia atípica durante el tratamiento con perampanel
Rodríguez, A. D., Extremera, V. C., Fernández, M. G., Peñas, J. J. G., & Rojas, M. L. R.-F. (2019) · Anales de Pediatría · doi:10.1016/j.anpedi.2019.01.015 · Cited by 1 · see citing works
Drug-Induced Seizures in Critically Ill Patients
Rhoney, D. H., & Shepherd, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-49557-6_20 · Cited by 1 · see citing works
Auvin, S. (2014) · EMC - Pediatría · doi:10.1016/s1245-1789(14)67013-x · Cited by 1 · see citing works
Induced atypical absence seizures during treatment with perampanel
Rodríguez, A. D., Extremera, V. C., Fernández, M. G., Peñas, J. J. G., & Rojas, M. L. R.-F. (2019) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2019.01.014 · Cited by 1 · see citing works
Management of Childhood Epilepsy Syndromes
Ferrie, C. D. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch14 · Cited by 1 · see citing works
Management of Epilepsy in People with Intellectual Disabilities
Brodtkorb, E. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch15 · Cited by 1 · see citing works
Medikamentöse Langzeittherapie von Epilepsien
Neubauer, B. A., & Hahn, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-41954-6_19
Conceptos básicos de la epilepsia infantil
Díaz, R. A. S. (2008) · Neurología
Dramatic Aggravation of Partial Seizures Induced by Gabapentin Overdose
Kobayashi, K., Takeuchi, A., Oka, M., Endoh, F., Yoshinaga, H., & Ohtsuka, Y. (2008) · Epilepsy & Seizure · doi:10.3805/eands.1.40
THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
Мukhin, К. Y., & Пылаева, О. А. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17650/2073-8803-2014-9-2-30-31
Outcome of pediatric epilepsies in adulthood
Gourfinkel‐An, I., & Dubeau, F. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00084-1
Best Practices in Neurological Care
Ovbiagele, B. (2014) · doi:10.2217/9781780842790
Viteri, C. (2009)
Rufinamide in patients with Lennox-Gastaut syndrome
Clark, P. O., & Gibson, P. A. (2016) · Nursing Research and Reviews · doi:10.2147/nrr.s116114
Zheng, T. W. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
김영미, 남상욱, Min, Y. G., 이윤진, 윤리라, & 공주현 (2017) · Annals of Child Neurology · doi:10.26815/jkcns.2017.25.3.139
Anticonvulsant Agents: Pharmacology and Biochemistry
Löscher, W. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_466-1
- Authors
- Gayatri, N., & Livingston, J.
- Affiliations
- Leeds Teaching Hospitals NHS Trust (GB)
- Corresponding author
- Gayatri, NA
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 2006-05
- Volume
- 48
- Issue
- 5
- Pages
- 394-398
- ISSN
- 0012-1622 (ISSN-L)
- 1469-8749
- OpenAlex
- W2150292807
- Cited by
- 114
- References
- 45
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 9 · 2016: 5 · 2015: 8 · 2014: 10 · 2013: 4 · 2012: 8
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Developmental Medicine & Child Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Pharmacology › Drug-Induced Adverse Reactions
- Keywords
- antiepileptic drugs, adverse drug reactions, carbamazepine, idiopathic generalized epilepsy, myoclonic epilepsy, valproic acid, status epilepticus, paradoxical drug reaction, drug-induced encephalopathy, pharmacogenomics, risk factors, seizure frequency
- MeSH terms
- Anticonvulsants, Child, Epilepsy, Humans, Severity of Illness Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review